|
CLSPN expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.319500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.919600E-02 |
| Normal-vs-Stage2 |
5.379000E-01 |
| Normal-vs-Stage3 |
8.031600E-02 |
| Normal-vs-Stage4 |
1.732960E-01 |
| Stage1-vs-Stage2 |
1.035580E-01 |
| Stage1-vs-Stage3 |
7.241800E-01 |
| Stage1-vs-Stage4 |
5.154400E-01 |
| Stage2-vs-Stage3 |
2.197600E-01 |
| Stage2-vs-Stage4 |
4.325400E-01 |
| Stage3-vs-Stage4 |
7.274200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.390000E-02 |
| Normal-vs-AfricanAmerican |
1.328410E-01 |
| Normal-vs-Asian |
2.747400E-01 |
| Caucasian-vs-AfricanAmerican |
9.258000E-01 |
| Caucasian-vs-Asian |
7.266500E-02 |
| AfricanAmerican-vs-Asian |
3.336600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.456800E-01 |
| Normal-vs-Female |
3.904100E-02 |
| Male-vs-Female |
6.836100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.412070E-02 |
| Normal-vs-Age(41-60Yrs) |
2.876800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.068360E-01 |
| Normal-vs-Age(81-100Yrs) |
3.394200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.739800E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.275600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.665800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.268400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.967000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.784600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.126400E-01 |
| Classical-VS-Follicular |
2.079900E-03 |
| Classical-VS-Other |
3.917200E-01 |
| Classical-VS-Normal |
2.317800E-02 |
| Tall-VS-Follicular |
4.295600E-02 |
| Tall-VS-Other |
3.680800E-01 |
| Tall-VS-Normal |
6.680300E-02 |
| Follicular-VS-Other |
8.629200E-01 |
| Follicular-VS-Normal |
6.853800E-01 |
| Other-VS-Normal |
7.597800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.001170E-01 |
| Normal-vs-N1 |
1.190790E-01 |
| N0-vs-N1 |
8.829000E-01 |
|
|
